Table 1.
Demographic Characteristics of the Sample
| ABBT (n = 40) | AR (n = 41) | χ2 or F | p | |
|---|---|---|---|---|
| Age M (SD) | 33.30 (12.42) | 32.56 (12.05) | 0.07 | .79 |
| Gender | 1.03 | .31 | ||
| Women | 60.0% (n = 24) | 70.7% (n = 29) | ||
| Men | 40.0% (n = 16) | 29.3% (n = 12) | ||
| Race/Ethnicity* | 0.38 | .54 | ||
| White | 77.5% (n = 31) | 82.9% (n = 34) | ||
| Hispanic/Latino(a) | 10.0% (n = 4) | 7.3% (n = 3) | ||
| Asian | 2.5% (n = 1) | 7.3% (n = 3) | ||
| Black | 5.0% (n = 2) | 2.4% (n = 1) | ||
| Middle Eastern | 2.5% (n = 1) | 0.0% (n = 0) | ||
| Biracial (Asian & White) | 2.5% (n = 1) | 0.0% (n = 0) | ||
| Previous Psychotherapy | 0.002 | .97 | ||
| Yes | 85.0% (n = 34) | 85.4% (n = 35) | ||
| No | 15.0% (n = 6) | 14.6% (n = 6) | ||
| Previous CBT/Skills-based Therapy | 0.004 | .95 | ||
| Yes | 22.5% (n = 9) | 22.0% (n = 9) | ||
| No | 75.0% (n = 30) | 75.6% (n = 31) | ||
| Taking Psychotropic Medication | 2.51 | .28 | ||
| Yes | 22.5% (n = 9) | 34.1% (n = 14) | ||
| No | 77.5% (n = 31) | 63.4% (n = 26) | ||
| SSRIs | 10.0% (n = 4) | 22.0% (n = 9) | ||
| Benzodiazepines | 15.0% (n = 6) | 4.9% (n = 2) | ||
| TCAs | 2.5% (n = 1) | 4.9% (n = 2) | ||
| Othera | 5.0% (n = 2) | 4.9% (n = 2) | ||
| Additional Diagnoses | 1.63 | .20 | ||
| Yes | 62.5% (n = 25) | 75.6% (n = 31) | ||
| No | 37.5% (n = 15) | 24.4% (n = 10) | ||
| Social Anxiety | 42.5% (n = 17) | 48.8% (n = 20) | ||
| Major Depression | 7.5% (n = 3) | 17.1% (n = 7) | ||
| Panic Disorder w/Ag | 7.5% (n = 3) | 17.1% (n = 7) | ||
| Specific Phobia | 10.0% (n = 4) | 4.9% (n = 2) | ||
| Eating Disorder NOS | 2.5% (n = 1) | 12.2% (n = 5) | ||
| OCD | 5.0% (n = 2) | 0.0% (n = 0) | ||
| PTSD | 2.5% (n = 1) | 2.4% (n = 1) | ||
| Otherb | 12.5% (n = 5) | 2.4% (n = 1) |
Note. ABBT = acceptance-based behavior therapy; AR = applied relaxation; CBT = cognitive behavioral therapy; SSRI = selective serotonin reuptake inhibitor; TCA = tricyclic antidepressant; NOS = not otherwise specified; OCD = obsessive-compulsive disorder; PTSD = post traumatic stress disorder.
*
Given the small sample size of individual groups, compared those who did and did not identify as White across treatments.
a
Other medications = SNRI, Buspar, Trazadone, and Propanalol.
b
Other additional diagnoses = dysthymia, panic disorder w/o agoraphobia, depressive disorder NOS, ADHD, impulse control NOS, and sexual disorder NOS